Feature | October 01, 2013 | Greg Freiherr


The world of personal pronouns has changed from when I was a kid. “That” has pushed “who” out of the picture, as in “he’s the patient that is showing signs of …” 

It’s a little unsettling. Not that long ago language was very clear, very precise. “Who” was for people; “that” was for things. Like magnetic resonance imaging (MRI) and its definition of multiple sclerosis (MS).

In the early 1980s, when the value of MRI as a clinical modality was being debated, the visualization of bright spots in the brains of MS patients exemplified what this fledgling technology could do.

Over the years, demyelinization of neurons, as seen with MRI, was recognized not only as a sign of this disease, but as an indicator of patient relapse or remission … even response to therapy. Then came the radiologically isolated syndrome (RIS).

RIS first appeared as an incidental finding. It was identified initially in 2008 as the presence of MRI-defined signs of MS in patients who do not have the clinical expression of the disease. The syndrome was first found in a patient undergoing a brain scan for an indication other than MS. It has since been identified in MS-free individuals who later developed clinical symptoms of the disease. 

One might conclude that RIS is preclinical indicator of MS. But why RIS patients do not have symptoms when the radiological signs of disease are clearly evident is not known. Which brings us back to “that.” 

The use of “that” is hardly purposeful. Most people, I imagine, don’t think about whether to use “that” or “who” — they just use one or the other and “that” is their choice. This is not so in diagnostic medicine. Diagnosticians are very deliberate. They don’t interpret an MRI out of context. They read it as part of a patient history, which is how RIS was discovered. The electronic medical record (EMR) provides the context in which to draw conclusions. And that may be the saving grace of diagnostic medicine as we move into the future.  

As technology evolves, what was once clear-cut is no longer.

Three Tesla (3.0T), for example, is the new clinical benchmark for MRI. At that field strength, scans deliver extraordinary detail compared to those done at 1.5T. At 7.0T, the images reveal even more detail. There are good reasons why 7.0T will never become a clinical standard, reasons that relate to the health of the patient. But, while an argument can be made that we will never go beyond 3.0T, I’ve learned to “never say never.”

We, therefore, must not only question what we are now seeing with today’s technology, but what it will mean as the technology continues to evolve. Will we see more RIS-like conditions for other diseases — more preclinical signs that may or may not develop into disease? And if we do, how do we make sense of these signs? 

The one constant we can be sure about is uncertainty. It is comforting to see how well we have done in our everyday lives.

When Abbott and Costello popularized their “Who’s on First” sketch, “who” was widely used as a personal pronoun. The humor of the sketch was based on the certainty of grammatical conventions. Over the years, humor and grammar have changed. I doubt today that audiences, especially young audiences, would understand the sketch, much less find it funny. But that’s OK. We continue to evolve.

Just as something as engrained as our sense of humor has changed, so will our definition of disease. I feel sure of “that.”

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group. Read more of his views on his blog at www.itnonline.com.

Related Content

Technology | Archive Cloud Storage | November 19, 2018
November 19, 2018 — Intelerad Medical Systems announced the launch of the nuage Disaster Recovery (DR) Platform.
Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
News | Enterprise Imaging | November 14, 2018
Konica Minolta Healthcare Americas Inc. will showcase new features and tools for the Exa Enterprise Imaging platform at...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Deaconess Health System Chooses Sectra as Enterprise Imaging Vendor
News | Enterprise Imaging | November 02, 2018
International medical imaging information technology (IT) and cybersecurity company Sectra will install its enterprise...
Carestream Spotlights Healthcare IT and Imaging Systems at RSNA 2018
News | Information Technology | October 31, 2018
Carestream announced it will be displaying several imaging and healthcare information technology (IT) offerings at the...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...